Published in Virology on January 05, 2005
Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol (2011) 1.77
Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol (2006) 1.46
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
Dynamics of filamentous viral RNPs prior to egress. Nucleic Acids Res (2007) 1.30
Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly. Mol Cell Proteomics (2010) 1.27
Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol (2010) 1.18
Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A (2009) 1.13
Cell cycle arrest by transforming growth factor beta1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol (2009) 1.07
Poxvirus cell entry: how many proteins does it take? Viruses (2012) 1.05
Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes. J Virol (2006) 1.04
Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. J Virol (2011) 1.04
The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol (2012) 1.03
Packaging of actin into Ebola virus VLPs. Virol J (2005) 1.02
The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. PLoS Pathog (2011) 1.01
Fusion-pore expansion during syncytium formation is restricted by an actin network. J Cell Sci (2008) 0.99
RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest (2014) 0.92
Roles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infection. PLoS Negl Trop Dis (2010) 0.90
Mouse norovirus 1 utilizes the cytoskeleton network to establish localization of the replication complex proximal to the microtubule organizing center. J Virol (2012) 0.90
Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol (2008) 0.89
Mutational analysis reveals a noncontractile but interactive role of actin and profilin in viral RNA-dependent RNA synthesis. J Virol (2009) 0.88
Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS One (2012) 0.87
The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion. Virology (2010) 0.86
Single-particle tracking demonstrates that actin coordinates the movement of the Ebola virus matrix protein. Biophys J (2012) 0.85
Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein. Mol Cell Proteomics (2015) 0.82
Cytoskeleton reorganization in influenza hemagglutinin-initiated syncytium formation. Biochim Biophys Acta (2008) 0.82
Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation. Viruses (2011) 0.81
F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol (2012) 0.81
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread. PLoS Pathog (2016) 0.80
Beet yellows virus replicase and replicative compartments: parallels with other RNA viruses. Front Microbiol (2013) 0.80
The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway Epithelia. J Virol (2015) 0.80
Genomewide association analysis of respiratory syncytial virus infection in mice. J Virol (2009) 0.79
Role for the αV Integrin Subunit in Varicella-Zoster Virus-Mediated Fusion and Infection. J Virol (2016) 0.77
Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol (2013) 0.77
Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy. Cancer Gene Ther (2013) 0.76
Proteome Response of Chicken Embryo Fibroblast Cells to Recombinant H5N1 Avian Influenza Viruses with Different Neuraminidase Stalk Lengths. Sci Rep (2017) 0.76
Interaction between Flavivirus and Cytoskeleton during Virus Replication. Biomed Res Int (2015) 0.76
Imaging analysis of human metapneumovirus-infected cells provides evidence for the involvement of F-actin and the raft-lipid microdomains in virus morphogenesis. Virol J (2014) 0.76
Paramyxovirus Glycoproteins and the Membrane Fusion Process. Curr Clin Microbiol Rep (2016) 0.76
Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus. Virol J (2016) 0.75
Host cytoskeleton in respiratory syncytial virus assembly and budding. Virol J (2016) 0.75
Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells. J Microsc (2013) 0.75
Novel mechanisms revealed in the trachea transcriptome of resistant and susceptible chicken lines following infection with Newcastle disease virus. Clin Vaccine Immunol (2017) 0.75
Fscn1 is required for the trafficking of TGF-β family type I receptors during endoderm formation. Nat Commun (2016) 0.75
RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane. Nat Commun (2017) 0.75
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med (2004) 7.71
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med (2010) 2.59
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A (2012) 2.42
Genetic basis for adverse events after smallpox vaccination. J Infect Dis (2008) 2.09
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis (2005) 2.02
Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol (2009) 1.94
Capturing the spectrum of interaction effects in genetic association studies by simulated evaporative cooling network analysis. PLoS Genet (2009) 1.91
A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol (2011) 1.85
Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol (2005) 1.75
Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol (2011) 1.68
Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe (2010) 1.66
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol (2009) 1.63
An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods (2008) 1.61
A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis (2005) 1.61
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol (2013) 1.60
Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A (2008) 1.55
Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant (2005) 1.54
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol (2011) 1.51
Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol (2010) 1.51
The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol (2005) 1.50
Single molecule-sensitive probes for imaging RNA in live cells. Nat Methods (2009) 1.40
Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. PLoS One (2012) 1.37
Pneumocystis carinii pneumonia in a girl with a midbrain glioma. Pediatr Hematol Oncol (2002) 1.37
A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med (2014) 1.37
Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A (2003) 1.33
Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis (2005) 1.32
A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology (2012) 1.30
Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis (2006) 1.29
Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods (2003) 1.27
Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J Infect Dis (2005) 1.26
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol (2007) 1.24
Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology (2005) 1.23
Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J Immunol (2003) 1.22
Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells. Mol Immunol (2006) 1.22
Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis (2010) 1.22
Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis (2004) 1.21
Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol (2012) 1.20
Retracted Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A (2014) 1.19
Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog (2012) 1.19
Machine learning competition in immunology - Prediction of HLA class I binding peptides. J Immunol Methods (2011) 1.18
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. J Infect Dis (2013) 1.16
Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol (2012) 1.13
Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J Immunol (2005) 1.12
Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol (2013) 1.12
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA (2004) 1.11
An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody. MBio (2011) 1.11
Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology (2008) 1.11
Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat Struct Mol Biol (2012) 1.11
Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol (2006) 1.10
Functional maturation of the human antibody response to rotavirus. J Immunol (2008) 1.09
Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology (2003) 1.09
VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J Immunol (2005) 1.08
The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence. J Virol (2005) 1.08
Coronavirus infection and hospitalizations for acute respiratory illness in young children. J Med Virol (2009) 1.08
Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol (2008) 1.06
Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology (2012) 1.05
Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J (2009) 1.04
Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine. J Infect Dis (2006) 1.04
Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol (2003) 1.03
The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr Infect Dis J (2009) 1.02
Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology (2011) 1.02
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol (2007) 1.02
Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes. Nano Lett (2005) 1.02
Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr (2010) 1.00
Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest (2013) 0.99
Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog (2011) 0.99
Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum Immunol (2005) 0.98
Independent structural domains in paramyxovirus polymerase protein. J Biol Chem (2012) 0.98
An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol (2008) 0.98
Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One (2013) 0.98
Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J Virol (2006) 0.97
Using the natural evolution of a rotavirus-specific human monoclonal antibody to predict the complex topography of a viral antigenic site. Immunome Res (2007) 0.96
Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother (2004) 0.94
Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol (2006) 0.94
Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. MBio (2012) 0.93
Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J Virol (2010) 0.92
Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol (2012) 0.92
Impact of new sequencing technologies on studies of the human B cell repertoire. Curr Opin Immunol (2013) 0.92
Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. J Clin Invest (2013) 0.92
The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Infect Immun (2002) 0.90
Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput Biol (2013) 0.89
Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol (2008) 0.89
Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays. J Immunol Methods (2011) 0.89
Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. MAbs (2013) 0.89
Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano (2013) 0.87
Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS One (2012) 0.87
The human neonatal B cell response to respiratory syncytial virus uses a biased antibody variable gene repertoire that lacks somatic mutations. Mol Immunol (2009) 0.86
Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. J Immunol (2013) 0.86
Genetic predisposition for adverse events after vaccination. J Infect Dis (2007) 0.86
Sagittal orientation of ingested coins in the esophagus in children. AJR Am J Roentgenol (2011) 0.85
Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies. Microbiol Spectr (2015) 0.85
Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood (2012) 0.85
Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells. Hum Immunol (2006) 0.84
Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Vaccine (2008) 0.84
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J Virol (2005) 0.84